{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T04:23:16Z","timestamp":1726806196688},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-024-04750-6","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T13:50:08Z","timestamp":1726753808000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["13-year survival oligometastatic Merkel cell carcinoma: a case report"],"prefix":"10.1186","volume":"18","author":[{"given":"I.","family":"Trampetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. C.","family":"Faivre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Geoffrois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Gehin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Renard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"key":"4750_CR1","first-page":"47","volume":"94","author":"A Stang","year":"2018","unstructured":"Stang A, Becker JC, Nghiem P, Ferlay J. The association between geographic location and incidence of Merkel cell carcinoma in comparison to melanoma: an international assessment. Eur J Cancer Oxf Engl 1990. 2018;94:47\u201360.","journal-title":"Eur J Cancer Oxf Engl 1990."},{"key":"4750_CR2","doi-asserted-by":"crossref","first-page":"17077","DOI":"10.1038\/nrdp.2017.77","volume":"3","author":"JC Becker","year":"2017","unstructured":"Becker JC, Stang A, DeCaprio JA, Cerroni L, Lebb\u00e9 C, Veness M, et\u00a0al. Merkel cell carcinoma. Nat Rev Dis Primer. 2017;3:17077.","journal-title":"Nat Rev Dis Primer"},{"issue":"3","key":"4750_CR3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaad.2007.11.020","volume":"58","author":"M Heath","year":"2008","unstructured":"Heath M, Jaimes N, Lemos B, Mostaghimi A, Wang LC, Pe\u00f1as PF, et\u00a0al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol. 2008;58(3):375\u201381.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"4750_CR4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bulcan.2018.11.009","volume":"106","author":"P T\u00e9tu","year":"2019","unstructured":"T\u00e9tu P, Baroudjian B, Madelaine I, Delyon J, Lebb\u00e9 C. Avanc\u00e9es th\u00e9rapeutiques r\u00e9centes dans la prise en charge du carcinome \u00e0 cellules de Merkel. Bull Cancer (Paris). 2019;106(1):64\u201372.","journal-title":"Bull Cancer (Paris)."},{"issue":"12","key":"4750_CR5","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1016\/j.annder.2014.09.049","volume":"141","author":"M Fondain","year":"2014","unstructured":"Fondain M, Dereure O, Guizard AV, Woronoff AS, Colonna M, Molinie F, et\u00a0al. \u00c9pid\u00e9miologie du carcinome \u00e0 cellules de Merkel en France. Ann Dermatol V\u00e9n\u00e9r\u00e9ologie. 2014;141(12):S240.","journal-title":"Ann Dermatol V\u00e9n\u00e9r\u00e9ologie."},{"issue":"16","key":"4750_CR6","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.ejca.2015.06.131","volume":"51","author":"C Lebbe","year":"2015","unstructured":"Lebbe C, Becker JC, Grob JJ, Malvehy J, del Marmol V, Pehamberger H, et\u00a0al. Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline. Eur J Cancer. 2015;51(16):2396\u2013403.","journal-title":"Eur J Cancer"},{"issue":"1","key":"4750_CR7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-0560.2009.01370.x","volume":"37","author":"J Albores-Saavedra","year":"2010","unstructured":"Albores-Saavedra J, Batich K, Chable-Montero F, Sagy N, Schwartz AM, Henson DE. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol. 2010;37(1):20\u20137.","journal-title":"J Cutan Pathol"},{"issue":"5866","key":"4750_CR8","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.1152586","volume":"319","author":"H Feng","year":"2008","unstructured":"Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319(5866):1096\u2013100.","journal-title":"Science"},{"issue":"11","key":"4750_CR9","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1245\/s10434-016-5266-4","volume":"23","author":"KL Harms","year":"2016","unstructured":"Harms KL, Healy MA, Nghiem P, Sober AJ, Johnson TM, Bichakjian CK, et\u00a0al. Analysis of prognostic factors from 9387 Merkel cell carcinoma cases forms the Basis for the New 8th Edition AJCC Staging System. Ann Surg Oncol. 2016;23(11):3564\u201371.","journal-title":"Ann Surg Oncol"},{"issue":"6\u20137","key":"4750_CR10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.annder.2011.01.029","volume":"138","author":"O Boccara","year":"2011","unstructured":"Boccara O, Girard C, Mortier L, Bens G, Saiag P, Guillot B, et\u00a0al. Guidelines for the diagnosis and treatment of Merkel cell carcinoma. Ann Dermatol Venereol. 2011;138(6\u20137):475\u201382.","journal-title":"Ann Dermatol Venereol"},{"key":"4750_CR11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fonc.2013.00276","volume":"3","author":"S Hasan","year":"2013","unstructured":"Hasan S, Liu L, Triplet J, Li Z, Mansur D. The role of postoperative radiation and chemoradiation in merkel cell carcinoma: a systematic review of the literature. Front Oncol. 2013;3:276.","journal-title":"Front Oncol"},{"key":"4750_CR12","unstructured":"NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) Merkel Cell Carcinoma [Internet]. Disponible sur: https:\/\/merkelcell.org\/wp-content\/uploads\/2021\/02\/NCCN-2021.pdf."},{"issue":"10","key":"4750_CR13","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S1470-2045(16)30364-3","volume":"17","author":"HL Kaufman","year":"2016","unstructured":"Kaufman HL, Russell J, Hamid O, Bhatia S, Terheyden P, D\u2019Angelo SP, et\u00a0al. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial. Lancet Oncol. 2016;17(10):1374\u201385.","journal-title":"Lancet Oncol"},{"issue":"9","key":"4750_CR14","doi-asserted-by":"crossref","first-page":"e180077","DOI":"10.1001\/jamaoncol.2018.0077","volume":"4","author":"SP D\u2019Angelo","year":"2018","unstructured":"D\u2019Angelo SP, Russell J, Lebb\u00e9 C, Chmielowski B, Gambichler T, Grob JJ, et\u00a0al. Efficacy and safety of first-line avelumab treatment in patients with stage IV metastatic merkel cell carcinoma: a preplanned interim analysis of a clinical trial. JAMA Oncol. 2018;4(9):e180077.","journal-title":"JAMA Oncol"},{"issue":"6","key":"4750_CR15","doi-asserted-by":"crossref","first-page":"742","DOI":"10.6004\/jnccn.2018.0055","volume":"16","author":"CK Bichakjian","year":"2018","unstructured":"Bichakjian CK, Olencki T, Aasi SZ, Alam M, Andersen JS, Blitzblau R, et\u00a0al. Merkel cell carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw JNCCN. 2018;16(6):742\u201374.","journal-title":"J Natl Compr Cancer Netw JNCCN."},{"issue":"14","key":"4750_CR16","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2217\/fon-2017-0072","volume":"13","author":"P Nghiem","year":"2017","unstructured":"Nghiem P, Kaufman HL, Bharmal M, Mahnke L, Phatak H, Becker JC. Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma. Future Oncol Lond Engl. 2017;13(14):1263\u201379.","journal-title":"Future Oncol Lond Engl"},{"issue":"10","key":"4750_CR17","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1200\/JCO.2005.02.329","volume":"23","author":"PJ Allen","year":"2005","unstructured":"Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23(10):2300\u20139.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"issue":"9","key":"4750_CR18","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/cam4.815","volume":"5","author":"JG Iyer","year":"2016","unstructured":"Iyer JG, Blom A, Doumani R, Lewis C, Tarabadkar ES, Anderson A, et\u00a0al. Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma. Cancer Med. 2016;5(9):2294\u2013301.","journal-title":"Cancer Med"},{"issue":"5","key":"4750_CR19","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/0360-3016(94)00610-W","volume":"32","author":"JH Leonard","year":"1995","unstructured":"Leonard JH, Ramsay JR, Kearsley JH, Birrell GW. Radiation sensitivity of Merkel cell carcinoma cell lines. Int J Radiat Oncol Biol Phys. 1995;32(5):1401\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"4750_CR20","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ijrobp.2009.08.011","volume":"78","author":"M Veness","year":"2010","unstructured":"Veness M, Foote M, Gebski V, Poulsen M. The role of radiotherapy alone in patients with merkel cell carcinoma: reporting the Australian experience of 43 patients. Int J Radiat Oncol Biol Phys. 2010;78(3):703\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"4750_CR21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.canlet.2013.09.018","volume":"356","author":"S Siva","year":"2015","unstructured":"Siva S, MacManus MP, Martin RF, Martin OA. Abscopal effects of radiation therapy: a clinical review for the radiobiologist. Cancer Lett. 2015;356(1):82\u201390.","journal-title":"Cancer Lett"},{"issue":"1","key":"4750_CR22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40425-017-0310-x","volume":"6","author":"HL Kaufman","year":"2018","unstructured":"Kaufman HL, Russell JS, Hamid O, Bhatia S, Terheyden P, D\u2019Angelo SP, et\u00a0al. Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after \u22651\u00a0year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial. J Immunother Cancer. 2018;6(1):7.","journal-title":"J Immunother Cancer"},{"issue":"26","key":"4750_CR23","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa1603702","volume":"374","author":"PT Nghiem","year":"2016","unstructured":"Nghiem PT, Bhatia S, Lipson EJ, Kudchadkar RR, Miller NJ, Annamalai L, et\u00a0al. PD-1 blockade with pembrolizumab in advanced merkel-cell carcinoma. N Engl J Med. 2016;374(26):2542\u201352.","journal-title":"N Engl J Med"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04750-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-024-04750-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04750-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T13:53:41Z","timestamp":1726754021000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-024-04750-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4750"],"URL":"https:\/\/doi.org\/10.1186\/s13256-024-04750-6","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,18]]},"assertion":[{"value":"18 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written patient consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial interests and no potential conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"455"}}